The NHS should not deny treatment to patients who pay privately for unapproved drugs, King's Fund chief executive Niall Dickson has said.
He told a seminar yesterday: 'The current practice on top-ups, which prohibits people from privately purchasing drugs not available on the health service while continuing a course of NHS care, is untenable.'
Listen to the debate at www.kingsfund.org.uk
Despite costing the NHS hundreds of millions of pounds annually, medicines waste remains largely invisible and unmeasured
The fortnightly newsletter that unpacks system leaders’ priorities for digital technology and the impact they are having on delivering health services. This week written by Ben Clover. Contact HSJ in confidence here.
Jon Spiers, CEO of the Royal Free Charity, makes the case for a strategic, government-backed approach to philanthropy – similar to the Blair-era matched funding scheme for universities – in health to complement and bolster state funding
HSJ is blessed with a very engaged readership. Each month our stories receive between 1,000-1,500 comments in total. This level of response is an order of magnitude greater than that enjoyed by most specialist titles.
We are aware that some of our users are experiencing problems accessing hsj.co.uk.
To protect your security as hsj.co.uk upgrades to a new platform, your existing password will no longer work.
No comments yet